Rivus Pharmaceuticals has filed a notice of an exempt offering of securities to raise $56,979,133.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Rivus Pharmaceuticals is raising up to $56,979,133.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold…